tci Medicare Compliance & Reimbursement - 2005 Issue 21
PHARMACEUTICALS: Rules For Multi-Drug Concurrent Infusion Vary By Area
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews CMS FAQ guidance on drug-administration billing and how much is left to local Medicare carriers to decide. It is aimed at coders, billing staff, and compliance professionals who need to understand the scope of Medicare Part B policy discussions affecting infusion and injection reporting. The article focuses on broad categories of drug-administration issues, local coverage variation, and CMS’s current position on unresolved billing questions.
Why This Topic Matters
Because CMS is deferring several drug-administration decisions to carriers, billing approaches may differ by jurisdiction. Readers who work with infusion, injection, and chemotherapy-administration claims need to know where national guidance ends and local policy becomes important.
What You Will Learn
- How CMS FAQ guidance can shift responsibility for drug-administration billing questions to local carriers
- Which broad drug-administration topics are addressed in the article
- Why local coverage decisions matter for certain Medicare Part B billing questions
- How the article frames unresolved questions involving concurrent infusion and repeated administration
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle professionals
- Compliance staff
- Medicare billing specialists
Codes Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com